personalized cancer therapy company ImmPact Bio raises $111 million
Erez Chimovits / Chairman of ImmPACT ImmPACT Bio, the next generation of cancer cell therapies, announced the completion of a $111 million fundraising round. The round was led by venBio Partners and co-led by Foresite Capital and Decheng Capital, as well as previous investors Novartis Venture Fund, RM Global Partners (RMGP), and Bukwang Pharmaceutical. ImmPACT […]
Continue Reading